Sign in

CIK 0000886163

  • Large accelerated filer

LIGAND PHARMACEUTICALS INC

Sign in to watch
Tickers
LGND LGNDZ LGNXZ LGNYZ LGNZZ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
770160744
Phone
+1 858-550-7500
Business address
7111 FAIRWAY DRIVE, SUITE 302, PALM BEACH GARDENS, FL, 33418
Former names
LIGAND PHARMACEUTICALS

Securities

  • LGND Common Stock Nasdaq
  • LGNDZ Common stock OTC
  • LGNXZ Common stock OTC
  • LGNYZ Common stock OTC
  • LGNZZ Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$7,384,247
in 9 filings, $4.7M under 10b5-1 plans

Net −$7,384,247. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-05-12 FOEHR MATTHEW W President and COO Exercise or conversion +5,621 $9.97 $56K 98,341
2017-05-12 FOEHR MATTHEW W President and COO Sale −5,621 $112.20 $631K 92,720
2017-05-12 FOEHR MATTHEW W President and COO Exercise or conversion · Employee Stock Option (right to buy) −5,621 52,235
2017-05-12 Aryeh Jason Director Sale −14,582 $111.87 $1.6M 116,651
2017-05-11 Aryeh Jason Director Sale −22,665 $110.04 $2.5M 131,233
2017-03-20 HIGGINS JOHN L Chief Executive Officer Sale −4,000 $109.10 $436K 139,171
2017-03-08 HIGGINS JOHN L Chief Executive Officer Sale −4,000 $107.06 $428K 128,969
2017-03-08 HIGGINS JOHN L Chief Executive Officer Exercise or conversion +15,675 $10.05 $158K 144,644
2017-03-08 HIGGINS JOHN L Chief Executive Officer Shares withheld for taxes −1,473 $106.92 $157K 143,171
2017-03-08 HIGGINS JOHN L Chief Executive Officer Exercise or conversion · Incentive Stock Option (right to buy) −15,675 0
2017-03-03 FOEHR MATTHEW W President and COO Exercise or conversion +2,000 $9.97 $20K 92,720
2017-03-03 FOEHR MATTHEW W President and COO Exercise or conversion · Employee Stock Option (right to buy) −2,000 57,856
2017-03-02 FOEHR MATTHEW W President and COO Exercise or conversion +6,879 $9.97 $69K 97,599
2017-03-02 FOEHR MATTHEW W President and COO Sale −6,879 $103.39 $711K 90,720
2017-03-02 FOEHR MATTHEW W President and COO Exercise or conversion · Employee Stock Option (right to buy) −6,879 59,856
2017-02-28 Aryeh Jason Director Sale −7,000 $107.58 $753K 153,898
2017-02-27 Aryeh Jason Director Sale −25,000 $106.00 $2.6M 160,898
2017-02-24 Berkman Charles S VP, Gen. Counsel & Secretary Grant or award +2,619 40,546
2017-02-24 Berkman Charles S VP, Gen. Counsel & Secretary Grant or award +2,259 42,805
2017-02-24 Berkman Charles S VP, Gen. Counsel & Secretary Grant or award · Employee Stock Option (right to buy) +9,643 9,643

Page 58 of 86 · 1,712 trades